Literature DB >> 18230256

External quality control of Mycobacterium tuberculosis drug susceptibility testing: results of two rounds in endemic countries.

L Fattorini1, E Iona, D Cirillo, G B Migliori, G Orefici, M Aziz, A Wright, S Tafaj, B Baig, G Mulliqi, S Maungate, Z Cuna, S Al-Busaidy, Z Al-Suwaidi, I Ceyhan.   

Abstract

SETTING: Quality assurance for the World Health Organization (WHO)/International Union Against Tuberculosis and Lung Disease (The Union) global tuberculosis (TB) drug resistance surveillance programme.
OBJECTIVE: To monitor the quality of drug susceptibility testing (DST) in different countries.
METHODS: In 2002-2003 and 2005-2006, 20 Mycobacterium tuberculosis strains were sent by the WHO/Union Supranational Reference Laboratory of Rome to TB reference laboratories in Albania, Bahrain, Kosovo, Mozambique, Oman, Qatar and Turkey for external quality control (EQC).
RESULTS: In 2002-2003, the specificity, sensitivity, efficiency, reproducibility and predictive values for resistance/susceptibility were >or=90% for streptomycin (SM), isoniazid (INH) and ethambutol (EMB). In 2005-2006, all statistical values were >or=96% for SM, INH, rifampicin and EMB.
CONCLUSION: EQC improved the quality of M. tuberculosis DST in the participating countries.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18230256

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  4 in total

1.  Performance of tuberculosis drug susceptibility testing in U.S. laboratories from 1994 to 2008.

Authors:  Pawan K Angra; Thomas H Taylor; Michael F Iademarco; Beverly Metchock; J Rex Astles; John C Ridderhof
Journal:  J Clin Microbiol       Date:  2012-02-01       Impact factor: 5.948

2.  First insight into genetic diversity of the Mycobacterium tuberculosis complex in Albania obtained by multilocus variable-number tandem-repeat analysis and spoligotyping reveals the presence of beijing multidrug-resistant isolates.

Authors:  Silva Tafaj; Jian Zhang; Yolande Hauck; Christine Pourcel; Hasan Hafizi; Grigor Zoraqi; Christophe Sola
Journal:  J Clin Microbiol       Date:  2009-03-11       Impact factor: 5.948

3.  External Quality Assessment for Tuberculosis Diagnosis and Drug Resistance in the European Union: A Five Year Multicentre Implementation Study.

Authors:  Vladyslav Nikolayevskyy; Doris Hillemann; Elvira Richter; Nada Ahmed; Marieke J van der Werf; Csaba Kodmon; Francis Drobniewski; Sabine Ruesch-Gerdes
Journal:  PLoS One       Date:  2016-04-07       Impact factor: 3.240

4.  First evaluation after implementation of a quality control system for the second line drug susceptibility testing of Mycobacterium tuberculosis joint efforts in low and high incidence countries.

Authors:  Doris Hillemann; Sven Hoffner; Daniela Cirillo; Francis Drobniewski; Elvira Richter; Sabine Rüsch-Gerdes
Journal:  PLoS One       Date:  2013-10-11       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.